Conduite à tenir devant un nodule thyroïdien isolé ou au sein d’un goître multi- hétéro-nodulaire. Quand on ne dispose pas de scintigraphie thyroïdienne (Tahiti) . CAT DEVANT UN NODULE THYROIDIEN PowerPoint Presentation, PPT – DocSlides- A. HMRUC. Le nodule. thyroïdien est très fréquent. Le cancer. an isolated thyroid nodule] Conduite à tenir devant un nodule thyroïdien isolé. Le nodule thyroïdien constitue la pathologie la plus fréquente des thyroïdies.

Author: Taramar Goltigor
Country: Mexico
Language: English (Spanish)
Genre: Sex
Published (Last): 13 December 2016
Pages: 186
PDF File Size: 20.11 Mb
ePub File Size: 9.49 Mb
ISBN: 710-3-22423-632-1
Downloads: 64975
Price: Free* [*Free Regsitration Required]
Uploader: Dour

Chimioembolisation [Zappa ] Contre-indications: Streptozocin-based chemotherapy is not history in neuroendocrine tumours. Efficacy and tolerability of pegylated IFN-alpha in patients with neuroendocrine gastroenteropancreatic carcinomas. Chromosomal alterations and germline inositol polyphosphate multikinase sequencing.

International Angency for Research on Cancer O6-methylguanine DNA methyltransferase deficiency and response to temozolomide-based therapy in patients with neuroendocrine tumors.

Examens morphologiques initiaux Efficacy of everolimus in patients with metastatic insulinoma and refractory hypoglycemia. Jpn J Clin Oncol. Comment citer ce chapitre? If you do not already have an account you will need to register here. In conclusion, the authors suggest that a thyroid nodule does not offer diagnostic or therapeutic problems and aspiration cytology has shown its efficacy by decreasing the tthyroidien of automatic surgical procedures performed on cold nodules.


Efficacy of a chemotherapy combination for the treatment of metastatic neuroendocrine tumours.

Are they really heterogeneous? The doxorubicin-streptozotocin combination for the treatment of advanced well-differentiated pancreatic endocrine carcinoma; a judicious option?

WHO classification of neoplasms of the neuroendocrine pancreas. Enter your login details below.

[Management of an isolated thyroid nodule] |

MGMT expression predicts response to temozolomide in pancreatic neuroendocrine tumors. Captures, Mentions, Social Media and Citations. Track accepted paper Once production of your article has started, you can track the status of your article via Track Your Accepted Article. In dvant to clinical Review and Position Statement.

Suspicion de tumeur mixte noduoe un contingent neuroendocrine. A thyroid nodule is the most frequent of thyroid pathologies, it includes hot and cold nodules. This free service is available to anyone who has published and whose publication is in Scopus. Username Password I forgot my password Register new account.

Nomenclature and classification of neuroendocrine neoplasms of the digestive system.

Prediction and diagnosis of bone metastases in well-differentiated gastro-entero-pancreatic endocrine cancer: Identifying it as benign or malignant remains the problem posed by this pathology. Fazio N, Milione M. Pour en savoir plus: DTIC therapy in patients with malignant intraabdominal neuroendocrine tumors. Submit Devamt Paper Enter your login details below. Sunitinib malate for the treatment of pancreatic neuroendocrine tumors.


Endoc – Online Flashcards by Ilo Raza | Brainscape

View More on Journal Insights. Entre 1 et 2 cm: Liver-directed therapies in liver metastases from neuroendocrine tumors of the gastrointestinal tract. Your Research Data Share your research data Visualize your data. Diagnosis and Prognostic Stratification. Best Pract Res Clin Gastroenterol. Indications du traitement antitumoral non chirurgical: Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin.


Médecine Nucléaire

A phase II study of irinotecan with 5-fluorouracil and leucovorin in patients with pretreated gastroenteropancreatic well-differentiated endocrine carcinomas.

Go here to learn more about PlumX Metrics. Options Irinotecan-cisplatine [Nakano ] niveau de la recommandation: Ki index, tumor differentiation, and extent of liver involvement are independent prognostic factors in patients with liver ndule of digestive endocrine carcinomas.